Concepedia

Kevin T. Love

KT

Statistics

Publications

20

Citations

5.8K

H-Index

20

Active since

2009

Affiliations

Massachusetts Institute of Technology(Current)

Harvard–MIT Division of Health Sciences and Technology

Alnylam Pharmaceuticals (United States)

Harvard University

Boston Children's Hospital

Kevin T. Love is an author at Massachusetts Institute of Technology specializing in drug delivery, pharmacy, and pharmaceutics.

Publications per year

2009–2016

20

Publications

20

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

Hyukjin Lee, Abigail K. R. Lytton‐Jean, Yi Chen et al. · Nature Nanotechnology · 2012 · 1.2K citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +14

Lipid-like materials for low-dose, in vivo gene silencing

Kevin T. Love, Kerry P. Mahon, Christopher G. Levins et al. · Proceedings of the National Academy of Sciences · 2010 · 965 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Therapeutic siRNA silencing in inflammatory monocytes in mice

Florian Leuschner, Partha Dutta, Rostic Gorbatov et al. · Nature Biotechnology · 2011 · 837 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Yizhou Dong, Kevin T. Love, J. Robert Dorkin et al. · Proceedings of the National Academy of Sciences · 2014 · 481 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation

Delai Chen, Kevin T. Love, Yi Chen et al. · Journal of the American Chemical Society · 2012 · 418 citations

Pharmacy, Biotechnology, Pharmaceutics +17

1–5 of 20